InvestorsHub Logo

williamssc

05/22/15 12:14 PM

#103827 RE: 1400 #103707

Reporting Increased Enrollment in Cellceutix's Clinical Trial of New Cancer Drug and also seeking Phase 2/3 Trial of a specific cancer in the same PR is huge news. The potential to see more then one phase 2/3 trials come out of this phase 1 is possible. This is another huge development for this little biotech. Congratulations to Leo and company and to all us longs.